Trials / Completed
CompletedNCT00369980
Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Gunma University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
L-\[3-18F\]-α-methyltyrosine (FMT) is amino-acid tracer for positron emission tomography (PET), and is used for tumor detection because malignant tumor cells accumulate 18F-FMT based on the increased expression of amino-acid transporter. This study was conducted to investigate a usefulness of 18F-FMT PET in combination with 18F-FDG PET for the diagnosis of sarcoidosis in patients with suspected malignancy.
Conditions
Timeline
- Start date
- 1998-09-01
- Completion
- 2005-08-01
- First posted
- 2006-08-30
- Last updated
- 2006-11-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00369980. Inclusion in this directory is not an endorsement.